| Identification | Back Directory | [Name]
Dimesna | [CAS]
16208-51-8 | [Synonyms]
Dimesna
BNP-7787
Dimesnum
Ccris 5852
Double Mesna
DiMesna (BNP7787)
Mesna EP Impurity D
DIMESNA(SUBJECTTOPATENTFREE)
2,2'-Dithiobisethanesulfonic Acid
Disodium 2,2'-dithiodiethanesulfonate
Mesna Impurity 4(Mesna EP Impurity D)
Bis(2-sulfoethyl)disulfide disodium salt
Disodium 2,2`-dithio-bis-ethane sulphonate
Bis(2-sulfoethyl) persulfide disodium salt
Bis[2-sulfoethyl] persulfide disodium salt
Sodium 2,2'-disulfanediyldiethanesulfonate
beta,beta'-Sulfoethyldisulfide, disodium salt
2,2'-Dithiobis(ethanesulfonic acid sodium) salt
2,2'-Dithiodi-1-ethanesulfonic acid disodium salt
DIMESNA (DISODIUM 2,2'-DITHIOBISETHANE SULFONATE)
2,2'-dithiobis(ethanesulfonic acid), disodium salt
2,2'-dithiobis-ethanesulfonic acid, sodium salt(1:2)
ω,ω'-Ethanedisulfidedisulfonic Acid Disodium Salt
DISCONTINUED. Please see D460660 | [EINECS(EC#)]
240-337-2 | [Molecular Formula]
C4H8Na2O6S4 | [MDL Number]
MFCD00868218 | [MOL File]
16208-51-8.mol | [Molecular Weight]
326.34 |
| Hazard Information | Back Directory | [Chemical Properties]
White Solid | [Uses]
Dimesna reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs. |
|
|